The Discounted Cash Flow (DCF) valuation of Seres Therapeutics Inc (MCRB) is 11.23 USD. With the latest stock price at 8.80 USD, the upside of Seres Therapeutics Inc based on DCF is 27.6%.
Based on the latest price of 8.80 USD and our DCF valuation, Seres Therapeutics Inc (MCRB) is a buy. buying MCRB stocks now will result in a potential gain of 27.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.3% | 7.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 9.12 - 19.38 | 11.23 |
| Upside | 3.7% - 120.2% | 27.6% |